Related Experiment Video

Updated: Aug 14, 2026

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model
05:35

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Published on: August 25, 2020

[Atherosclerosis not caused by overindulgence only. Infection may be a risk factor for cardiovascular disease]

L Schäfer Elinder1, J Frostegård

  • 1Konung Gustaf V:s Forskningsinstitut, Karolinska institutet, Stockholm.

Lakartidningen
|June 12, 1998
PubMed

Insights

Vascular inflammation, often triggered by infections or autoimmune diseases, plays a key role in atherosclerosis and cardiovascular disease development. Understanding these links may lead to new prevention and treatment strategies for arterial disease.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pathophysiology

Context:

  • Growing evidence links infections and autoimmune diseases to cardiovascular disease.
  • Vascular inflammation is increasingly recognized as a critical factor in atherogenesis.
  • Conditions like rheumatoid arthritis and systemic lupus erythematosus elevate cardiovascular risks.

Purpose:

  • To explore the role of vascular inflammation in atherosclerosis.
  • To investigate the connection between infections, autoimmune diseases, and cardiovascular disease.
  • To highlight how inflammatory cytokines impact lipid metabolism and endothelial function.

Summary:

  • Inflammatory cytokines, implicated in autoimmune conditions and infections, significantly influence lipid metabolism and endothelial function.
  • These inflammatory processes contribute to the development of arterial disease, a hallmark of atherosclerosis.
  • The study emphasizes the link between systemic inflammation and the progression of cardiovascular pathology.

Impact:

  • Provides a foundation for novel therapeutic strategies targeting vascular inflammation.
  • Offers insights into the prevention and treatment of atherosclerosis and related cardiovascular diseases.
  • Enhances understanding of the complex interplay between inflammation, immunity, and vascular health.

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...